FDA accepts Bayer’s finerenone application for non-diabetic kidney disease
Details
The full article is available to subscribers.
Products and related news
Request a free newsletter trial covering your products and business interests.
Request a free trialOur team will confirm activation and access. A trial request does not automatically unlock this article.

